Cambridge Cognition Holdings (LSE:COG) Research & Development: £2.43 Mil (TTM As of Dec. 2025)


LSE:COG Cambridge Cognition Holdings PLC LSE:COG
45 GF Score
Price £0.35
GF Value £0.33
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cambridge Cognition Holdings Research & Development?

Cambridge Cognition Holdings LSE:COG -1.43% 45 Research & Development is £2.43 Mil as of Dec. 2025. GuruFocus rates LSE:COG with a GF Score™ of 45/100 and a GF Value™ of £0.33 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cambridge Cognition Holdings's Research & Development for the six months ended in Dec. 2025 was £1.36 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £2.43 Mil.

Cambridge Cognition Holdings  (LSE:COG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cambridge Cognition Holdings Research & Development Related Terms

Cambridge Cognition Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Cambridge Cognition Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Cognition Holdings Research & Development Chart

Cambridge Cognition Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2.29 3.85 3.00 2.43

Cambridge Cognition Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 1.40 1.60 1.07 1.36
LSE:COG
45GF Score
Cambridge Cognition Holdings PLC LSE:COG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cambridge Cognition Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £2.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £2.43 Mil mean?
Cambridge Cognition Holdings (LSE:COG) has a Research & Development of £2.43 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cambridge Cognition Holdings and its competitors.
Is Cambridge Cognition Holdings' Research & Development too high?
Cambridge Cognition Holdings' current Research & Development is £2.43 Mil. Overall, Cambridge Cognition Holdings has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' Research & Development compare to VEEV and BTSG?
Cambridge Cognition Holdings' Research & Development of £2.43 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cambridge Cognition Holdings and its competitors. Cambridge Cognition Holdings's current Research & Development is £2.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (LSE:COG) is currently considered Fairly Valued. The stock's GF Value™ is £0.33, compared to a current price of £0.35 — trading 4.5% above its estimated fair value. The current Research & Development is £2.43 Mil. Cambridge Cognition Holdings' overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cambridge Cognition Holdings (LSE:COG), the current Research & Development is £2.43 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?

Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be overvalued. The current stock price of £0.35 is trading 4.5% above its estimated GF Value™ of £0.33. GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.

Key valuation signals for LSE:COG:

  • Research & Development: £2.43 Mil
  • GF Value™: £0.33 vs. price of £0.35 (4.5% above fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cambridge Cognition Holdings Business Description

Other Exchanges 1M7:Germany
Address Tunbridge Lane, Tunbridge Court, Bottisham, Cambridge, GBR, CB25 9TU
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
45GF Score

Get the complete analysis for LSE:COG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.35
Price
£0.33
GF Value